<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Medical Microbiology and Infectious Diseases</title>
<title_fa>Journal of Medical Microbiology and Infectious Diseases</title_fa>
<short_title>JoMMID</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jommid.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2345-5349</journal_id_issn>
<journal_id_issn_online>2345-5330</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/JoMMID</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>9</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The Effect of Silibinin on the Expression of TLR7, ISG15, and SOCS1 in Peripheral Blood Mononuclear Cells of Hepatitis C Infected Patients in Comparison with Interferon-α</title>
	<subject_fa>Infectious diseases and public health</subject_fa>
	<subject>Infectious diseases and public health</subject>
	<content_type_fa>Original article</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Introduction: &lt;/strong&gt;Silibinin (silibinin A) is the most active silymarin component, which acts both as a hepatoprotective [1] and an antiviral agent. The present study investigated the silibinin effect on IFN-related innate immune genes in PBMCs from HCV-infected patients.&lt;strong&gt; Method:&lt;/strong&gt; 22 chronic HCV patients, including 10 IFN responders and 12 non-responders, were included. Their isolated PBMCs were treated for 6 hours in the presence of silibinin, IFN-&amp;alpha;, or their combination. The transcription level of TLR7, ISG15, and SOCS1 genes was compared using real-time PCR.&lt;strong&gt; Result:&lt;/strong&gt; Our result showed that IFN-&amp;alpha; induced a significant up-regulation of TLR7 and ISG15 in PBMCs of both responder and non-responder groups. Nevertheless, the SOCS1 gene was not significantly changed in the non-responder group (P=0.32). The combination of IFN&amp;alpha;&lt;span dir=&quot;RTL&quot;&gt;-&lt;/span&gt; and silibinin showed a similar pattern to IFN-&amp;alpha; alone. By itself, silibinin did not leave a significant change on the expression level of the studied genes&lt;span dir=&quot;RTL&quot;&gt;. &lt;/span&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; The results indicated that silibinin did not enhance or suppress the expression level of TLR7, ISG15, and SOCS1 genes.&amp;nbsp; Therefore, it has been suggested that its anti-inflammatory role might be devoid of IFN pathways.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>HCV, Silibinin, Interferon, ISG15, SOCS1</keyword>
	<start_page>12</start_page>
	<end_page>16</end_page>
	<web_url>http://jommid.pasteur.ac.ir/browse.php?a_code=A-10-271-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Razieh</first_name>
	<middle_name></middle_name>
	<last_name>Dowran</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>raziehdowran@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-2318-4397</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Younes</first_name>
	<middle_name></middle_name>
	<last_name>Hosseini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>yovirus2002@yahoo.com</email>
	<code></code>
	<orcid>0000-0002-5881-6796</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad Reza</first_name>
	<middle_name></middle_name>
	<last_name>Fattahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fattahim@sums.ac.ir</email>
	<code></code>
	<orcid>0000-0001-6160-0403</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Gastroenterohepatology Research center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Jamal</first_name>
	<middle_name></middle_name>
	<last_name>Sarvari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sarvarij@sums.ac.ir</email>
	<code></code>
	<orcid>0000-0002-2259-0836</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.Gastroenterohepatology Research center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
